Effects of erythropoietin on posttraumatic place learning in fimbria-fornix transected rats after a 30-day postoperative pause

Journal of Neurotrauma

Volumn 24, Issue 10, 2007, Pages 1647-1657

  Malá, Hana ^a   Rodriguez Castro, Maria ^a   Dall Jørgensen, Katrine ^a   Mogensen, Jesper ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Brain injury; Erythropoietin; Functional recovery; Rat; Timing

Indexed keywords

RECOMBINANT ERYTHROPOIETIN; SODIUM CHLORIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN FORNIX; BRAIN INJURY; CONTROLLED STUDY; DRUG EFFECT; FIMBRIA; HIPPOCAMPUS; HISTOLOGY; LEARNING; MALE; MAZE TEST; NEUROPROTECTION; NONHUMAN; RAT; STATISTICAL ANALYSIS; TASK PERFORMANCE;

ANIMALS; AXOTOMY; BRAIN INJURIES; ERYTHROPOIETIN, RECOMBINANT; FORNIX, BRAIN; HUMANS; MALE; MAZE LEARNING; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; RECOVERY OF FUNCTION; TIME;

EID: 35648993458     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2007.0292     Document Type: Article

References (70)

1. ALAFACI, C., SALPIETRO, F., GRASSO, G., et al. (2000). Effects of recombinant human erythropoietin on cerebral ischemia following experimental subarachnoid hemorrhage. Eur. J. Pharmacol. 406, 219-225.
2. BERNAUDIN, M., MARTI, H.H., ROUSSEL, S., et al. (1999). A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 19, 643-651.
3. BERNAUDIN, M., BELLAIL, A., MARTI, H.H., et al. (2000). Neurons and astrocytes express EPO mRNA: oxygen-sensing mechanisms that involve the redox-state of the brain. Glia 30, 271-278.
4. BIERNASKIE, J., and CORBETT, D. (2001). Enriched rehabilitative training promotes improved forelimb motor function and enhanced dendritic growth after focal ischemic injury. J. Neurosci. 21, 5272-5280.
5. BIERNASKIE, J., CHERNENKO, G., and CORBETT, D. (2004). Efficacy of rehabilitative experience declines with time after focal ischemic brain injury. J. Neurosci. 24, 1245-1254.
6. BRETTSCHNEIDER, J., WIDL, K., EHRENREICH, H., RIEPE, M., and TUMANI, H. (2006). Erythropoietin in the cerebrospinal fluid in neurodegenerative diseases. Neurosci. Lett. 404, 347-351.
7. BRINES, M.L., GHEZZI, P., KEENAN, S., et al. (2000). Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc. Natl. Acad. Sci. USA 97, 10526-10531.
8. CATANIA, M.A., MARCIANO, M.C., PARISI, A., et al. (2002). Erythropoietin prevents cognition impairment induced by transient brain ischemia in gerbils. Eur. J. Pharmacol. 437, 147-150.
9. CELIK, M., GOKMEN, N., ERBAYRAKTAR, S., et al., (2002). Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. Proc. Natl. Acad. Sci. USA 99, 2258-2264.
10. CETIN, A., NAS, K., BUYUKBAYRAM, H., CEVIZ, A., and OLMEZ, G. (2006). The effects of systemically administered methylprednisolone and recombinant human erythropoietin after acute spinal cord compressive injury in rats. Eur. Spine J. 15, 1539-1544.
11. CHANG, Y.S., MU, D., WENDLAND, M., et al., (2005). Erythropoietin improves functional and histological outcome in neonatal stroke. Pediatr. Res. 58, 106-111.
12. CHIN, K., YU, X., BELESLIN-COKIC, B., et al. (2000). Production and processing of erythropoietin receptor transcripts in brain. Brain Res. Mol. Brain Res. 81, 29-42.
13. CHONG, Z.Z., KANG, J.Q., and MAIESE, K. (2003a). Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1, Bad, and caspase-mediated pathways. Br. J. Pharmacol. 138, 1107-1118.
14. CHONG, Z.Z., LIN, S.H., KANG, J.Q., and MAIESE, K. (2003b). Erythropoietin prevents early and late neuronal demise through modulation of Akt1 and induction of caspase 1, 3, and 8. J. Neurosci. Res. 71, 659-669.
15. CHONG, Z.Z., LI, F., and MAIESE, K. (2005). Erythropoietin requires NF-kappaB and its nuclear translocation to prevent early and late apoptotic neuronal injury during beta-amyloid toxicity. Curr. Neurovasc. Res. 2, 387-399.
16. DAHLQVIST, P., ZHAO, L., JOHANSSON, I.M., et al. (1999). Environmental enrichment alters nerve growth factor-induced gene A and glucocorticoid receptor messenger RNA expression after middle cerebral artery occlusion in rats. Neuroscience 93, 527-535.
17. DEMERS, E.J., MCPHERSON, R.J., and JUUL, S.E. (2005). Erythropoietin protects dopaminergic neurons and improves neurobehavioral outcomes in juvenile rats after neonatal hypoxia-ischemia. Pediatr. Res. 58, 297-301.
18. DIEM, R., SATTLER, M.B., MERKLER, D., et al. (2005). Combined therapy with methylprednisolone and erythropoietin in a model of multiple sclerosis. Brain 128, 375-385.
19. DIGICAYLIOGLU, M., BICHET, S., MARTI, H.H., et al. (1995). Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc. Natl. Acad. Sci. USA 92, 3717-3720.
20. EHRENREICH, H., DEGNER, D., MELLER, J., et al. (2004). Erythropoietin: a candidate compound for neuroprotection in schizophrenia. Mol. Psychiatry 9, 42-54.
21. GENC, S., KURALAY, F., GENC, K., et al. (2001). Erythropoietin exerts neuroprotection in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57/BL mice via increasing nitric oxide production. Neurosci. Lett. 298, 139-141.
22. GENC, S., EGRILMEZ, M.Y., and GENC, K. (2006). Endothelial nitric oxide-mediated Nrf2 activation as a novel mechanism for vascular and neuroprotection by erythropoietin in experimental subarachnoid hemorrhage. Med. Hypotheses 67, 424.
23. GOINGS, G.E., WIBISONO, B.L., and SZELE, F.G. (2002). Cerebral cortex lesions decrease the number of bromodeoxyuridine-positive subventricular zone cells in mice. Neurosci. Lett. 329, 161-164.
24. GOINGS, G.E., SAHNI, V., and SZELE, F.G. (2004). Migration patterns of subventricular zone cells in adult mice change after cerebral cortex injury. Brain Res. 996, 213-226.
25. GRASSO, G. (2001). Neuroprotective effect of recombinant human erythropoietin in experimental subarachnoid hemorrhage. J. Neurosurg. Sci. 45, 7-14.
26. GRASSO, G. (2006). Erythropoietin: a new paradigm for neuroprotection. J. Neurosurg. Anesthesiol. 18, 91-92.
27. GRASSO, G., BUEMI, M., ALAFACI, C., et al. (2002). Beneficial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage. Proc. Natl. Acad. Sci. USA 99, 5627-5631.
28. GRASSO, G., SFACTERIA, A., CERAMI, A., and BRINES, M. (2004). Erythropoietin as a tissue-protective cytokine in brain injury: what do we know and where do we go? Neuroscientist 10, 93-98.
29. GRASSO, G., SFACTERIA, A., PASSALACQUA, M., et al. (2005). Erythropoietin and erythropoietin receptor expression after experimental spinal cord injury encourages therapy by exogenous erythropoietin. Neurosurgery 56, 821-827.
30. GRASSO, G., SFACTERIA, A., ERBAYRAKTAR, S., et al. (2006). Amelioration of spinal cord compressive injury by pharmacological preconditioning with erythropoietin and a nonerythropoietin deriative. J. Neurosurg. Spine 4, 310-318.
31. JUUL, S.E., ANDERSON, D.K., LI, Y., and CHRISTENSEN, R.D. (1998a). Erythropoietin and erythropoietin receptor in the developing human central nervous system. Pediatr. Res. 43, 40-49.
32. JUUL, S.E., YACHNIS, A.T., and CHRISTENSEN, R.D. (1998b). Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus. Early Hum. Dev. 52, 235-249.
33. KAPTANOGLU, E., SOLAROGLU, I., OKUTAN, O., SURUCU, H.S., AKBIYIK, F., and BESKONAKLI, E. (2004). Erythropoietin exerts neuroprotection after acute spinal cord injury in rats: effect on lipid peroxidation and early ultrastructural findings. Neurosurg. Rev. 27, 113-120.
34. KAWAMATA, T., ALEXIS, N.E., DIETRICH, W.D., and FINKELSTEIN, S.P. (1996). Intracisternal basic fibroblast growth factor (bFGF) enhances behavioral recovery following focal cerebral infarction in the rat. J. Cereb. Blood Flow Metab. 16, 542-547.
35. KONISHI, Y., CHUI, D.-H., HIROSE, H., KUNISHITA, T., and TABIRA, T. (1993). Trophic effect of erythropoietin and other hematopoietic factors on central cholinergic neurons in vitro and in vivo. Brain Res. 609, 29-35.
36. KUMRAL, A., BASKIN, H., GOKMEN, N., et al. (2004a). Selective inhibition of nitric oxide in hypoxic-ischemic brain model in newborn rats: is it an explanation for the protective role of erythropoietin? Biol. Neonata 85, 51-54.
37. KUMRAL, A., UYSAL, N., TUGYAN, K., et al. (2004b). Erythropoietin improves long-term spatial memory deficits and brain injury following neonatal hypoxia-ischemia in rats. Behav. Brain Res. 153, 77-86.
38. KUMRAL, A., TUGYAN, K., GONENC, S., et al. (2005). Protective effects of erythropoietin against ethanol-induced apoptotic neurodegeneration and oxidative stress in the developing C57BL/6 mouse brain. Brain Res. Dev. Brain Res. 160, 146-156.
39. KUMRAL, A., GENC, S., OZER, E., et al. (2006). Erythropoietin downregulates bax and DP5 proapoptotic gene expression in neonatal hypoxic-ischemic brain injury. Biol. Neonate 89, 205-210.
40. LIPPERT-GRÜNER, M., MAEGELE, M., POKORNY, J., et al. (2007). Early rehabilitation model shows positive effects on neural degeneration and recovery from neuromotor deficits following traumatic brain injury. Physiol. Res. 56, 359-368.
41. LU, D., MAHMOOD, A., QU, C., GOUSSEV, A., SCHALLERT, T., and CHOPP, M. (2005). Erythropoietin enhances neurogenesis and restores spatial memory in rats after traumatic brain injury. J. Neurotrauma 22, 1011-1017.
42. MALÁ, H., ALSINA, C.G., MADSEN, K.S., SIBBESEN, E.C., STICK, H., and MOGENSEN, J. (2005). Erythropoietin improves place learning in an 8-arm radial maze in fimbriafornix transected rast. Neural Plast. 12, 329-340.
43. MARTI, H.H., WENGER, R.H., RIVAS, L.A., et al. (1996). Erythropoietin gene expression in human, monkey and murine brain. Eur. J. Neurosci. 8, 666-676.
44. MARTI, H.H., BERNAUDIN, M., PETIT, E., and BAUER, C. (2000). Neuroprotection and angiogenesis: dual role of erythropoietin in brain ischemia. News Physiol. Sci. 15, 225-229.
45. MASUDA, S., NAGAO, M., TAKAHATA, K., et al. (1993). Functional erythropoietin receptor of the cells with neural characteristics. Comparison with receptor properties of erythroid cells. J. Biol. Chem. 268, 11208-11216.
46. MASUDA, S., OKANO, M., YAMAGISHI, K., NAGAO, M., UEDA, M., and SASAKI, R. (1994). A novel site of erythropoietin production. Oxygen-dependent production in cultured rat astrocytes. J. Biol. Chem. 269, 19488-19493.
47. MOGENSEN, J., LAURITSEN, K.T., ELVERTORP, S., HASMAN, A., MOUSTGAARD, A., and WÖRTWEIN, G. (2004a). Place learning and object recognition by rats subjected to transection of the fimbria-fornix and/or ablation of the prefrontal cortex. Brain Res. Bull. 63, 217-236.
48. MOGENSEN, J., MISKOWIAK, K., SØRENSEN, T.A., et al. (2004b). Erythropoietin improves place learning in fimbriafornix transected rats and modifies the search pattern of normal rats. Pharmacol. Biochem. Behav. 77, 381-390.
49. MOGENSEN, J., MOUSTGAARD, A., KHAN, U., WÖRTWEIN, G., and NIELSEN, K.S. (2005). Egocentric spatial orientation in a water maze by rats subjected to transection of the fimbria-fornix and/or ablation of the prefrontal cortex. Brain Res. Bull. 65, 41-58.
50. MORISHITA, E., MASUDA, S., NAGAO, M., YASUDA, Y., and SASAKI, R. (1997). Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 76, 105-116.
51. PAXINOS, G., and WATSON, C. (1982). The Rat Brain in Stereotaxic Coordinates. Academic Press: Sydney.
52. RAMASWAMY, S., GOINGS, G.E., SODERSTROM, K.A., SZELE, F.G., and KOZLOWSKI, D.A. (2005). Cellular proliferation and migration following a controlled cortical impact in the mouse. Brain Res. 1053, 38-53.
53. ROESLER, R., QUEVEDO, J., and SCHRODER, N. (2004). Erythropoietin, glutamate, and neuroprotection. N. Engl. J. Med. 351, 1465-1466.
54. SADAMOTO, Y., IGASE, K., SAKANAKA, M., et al. (1998). Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery. Biochem. Biophys. Res. Commun. 253, 26-32.
55. SATTLER, M.B., MERKLER, D., MAIER, K., et al. (2004). Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis. Cell Death. Differ. 11, Suppl. 2, S181-S192.
56. SIGNORE, A.P., WENG, Z., HASTINGS, T., et al. (2006). Erythropoietin protects against 6-hydroxydopamine-induced dopaminergic cell death. J. Neurochem. 96, 428-443.
57. SPELIOTES, E.K., CADAY, C.G., DO, T., WEISE, J., KOWALL, N.W., and FINKLESTEIN, S.P. (1996). Increased expression of basic fibroblast growth factor (bFGF) following focal cerebral infarction in the rat. Brain Res. Mol. Brain Res. 39, 31-42.
58. SPRINGBORG, J.B., MA, X, ROCHAT, P., et al. (2002). A single subcutaneous bolus of erythropoietin normalizes cerebral blood flow autoregulation after subarachnoid haemorrhage in rats. Br. J. Pharmacol. 135, 823-829.
59. SPRINGBORG, J.B., SONNE, B., FREDERIKSEN, H.J., et al. (2003). Erythropoietin in the cerebrospinal fluid of patients with aneurysmal subarachnoid haemorrhage originates from the brain. Brain Res. 984, 143-148.
60. STROEMER, R.P., KENT, T.A., and HULSEBOSCH, C.E. (1995). Neocortical neural sprouting, synaptogenesis, and behavioral recovery after neocortical infarction in rats. Stroke 26, 2135-2144.
61. SUNDHOLM-PETERS, N.L., YANG, H.K., GOINGS, G.E., WALKER, A.S., and SZELE, F.G. (2005). Subventricular zone neuroblasts emigrate toward cortical lesions. J. Neuropathol. Exp. Neurol. 64, 1089-1100.
62. TAN, C.C., and RATCLIFFE, P.J. (1992). Rapid oxygen-dependent changes in erythropoietin mRNA in perfused rat kidneys: evidence against mediation by cAMP. Kidney Int. 41, 1581-1587.
63. TSAI, P.T., OHAB, J.J., KERTESZ, N., et al. (2006). A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery. J. Neurosci. 26, 1269-1274.
64. WANG, L., ZHANG, Z., WANG, Y., ZHANG, R., and CHOPP, M. (2004a). Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 35, 1732-1737.
65. WANG, L., ZHANG, Z., ZHANG, R., et al. (2004b). Erythropoietin up-regulates SOCS2 in neuronal progenitor cells derived from SVZ of adult rat. Neuroreport 15, 1225-1229.
66. WEI, L., HAN, B.H., LI, Y., KEOGH, C.L., HOLTZMAN, D.M., and YU, S.P. (2006). Cell death mechanism and protective effect of erythropoietin after focal ischemia in the whisker-barrel cortex of neonatal rats. J. Pharmacol. Exp. Ther. 317, 109-116.
67. YAMAJI, R., OKADA, T., MORIYA, M., et al. (1996). Brain capillary endothelial cells express two forms of erythropoietin receptor mRNA. Eur. J. Biochem. 239, 494-500.
68. YAMASAKI, M., MISHIMA, H.K., YAMASHITA, H., et al. (2005). Neuroprotective effects of erythropoietin on glutamate and nitric oxide toxicity in primary cultured retinal ganglion cells. Brain Res. 1050, 15-26.
69. YATSIV, I., GRIGORIADIS, N., SIMEONIDOU, C., et al. (2005). Erythropoietin is neuroprotective, improves functional recovery, and reduces neuronal apoptosis and inflammation in a rodent model of experimental closed head injury. FASEB J. 19, 1701-1703.
70. ZHANG, F., SIGNORE, A.P., ZHOU, Z., WANG, S., CAO, G., and CHEN, J. (2006). Erythropoietin protects CA1 neurons against global cerebral ischemia in rat: potential signalling mechanisms. J. Neurosci. Res. 83, 1241-1251.